Journal profile · PHARMACOLOGY & PHARMACY
Egyptian Pharmaceutical Journal
ISSN 1687-4315 · eISSN 2090-9853 · Wolters Kluwer Health
Egyptian Pharmaceutical Journal: CAS Zone 4 · Medicine (2025 upgraded edition); hybrid open access; 61 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Egyptian Pharmaceutical Journal is published by Wolters Kluwer Health and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Medicinal Plant Research, Enzyme Production and Characterization and Essential Oils and Antimicrobial Activity, together about 28% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): PHARMACOLOGY & PHARMACY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medicinal Plant ResearchAgricultural and Biological Sciences11.7%
- Enzyme Production and CharacterizationBiochemistry, Genetics and Molecular Biology9.9%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences6.5%
- Enzyme Catalysis and ImmobilizationBiochemistry, Genetics and Molecular Biology5.8%
- Synthesis and biological activityChemistry5.5%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics5%
- Microbial Natural Products and BiosynthesisMedicine4.4%
- Natural Antidiabetic Agents StudiesMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pharmaceutical Science | Q3 | 128/191 | 33rd |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.5LetPub ·
- SJR 2026-06
- 0.23LetPub ·
- SNIP 2026-06
- 0.29LetPub ·
- h-index
- 19OpenAlex ·
- i10-index
- 73OpenAlex ·
- 2-year mean citedness
- 0.81OpenAlex ·
- Self-citation rate
- 11.1%LetPub ·
- Share of gold OA articles
- 22.34%LetPub ·
Volume
- Articles per year
- 48LetPub ·
Articles by year OpenAlex count · 600 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 39 | 0 | 283 |
| 2025 | 61 | 23 | 370 |
| 2024 | 78 | 43 | 366 |
| 2023 | 76 | 10 | 395 |
| 2022 | 56 | 0 | 283 |
| 2021 | 39 | 7 | 273 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
Too few articlesOnly 1 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Health
- ISSN
- 1687-4315
- Electronic ISSN
- 2090-9853
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Egyptian Pharmaceutical Journal
What CAS zone is Egyptian Pharmaceutical Journal in?
In the 2025 upgraded edition of the CAS Journal Ranking, Egyptian Pharmaceutical Journal is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
Which databases index Egyptian Pharmaceutical Journal?
According to LetPub and DOAJ records, Egyptian Pharmaceutical Journal is indexed in ESCI and Scopus.
Is Egyptian Pharmaceutical Journal open access, and what is the APC?
Egyptian Pharmaceutical Journal is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .